Skip to main content
OpenTrials
Completed

NCT Number: NCT05406453

Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar

Tuberculosis (TB) whole genome sequencing (WGS) allows outbreak identification and disease transmission tracking.

It is hypothesized that prospective WGS-guided epidemiological investigations improve case detection compared to current best practices by adapting contact tracing strategies to local transmission patterns.

A cluster randomized controlled trial (cRCT) will be performed in high TB incidence villages of Haute Matsiatra region in Madagascar. Communities will be randomized in three separate TB control strategies comparing (1) standard of care, (2) the World Health Organization (WHO) recommended best practices and (3) a novel intervention involving TB WGS cluster-guided epidemiological investigations. The incremental value of TB WGS on case notifications and reduction of TB burden will be measured.

Secondary studies will be nested within this cRCT will include:

* A qualitative study which will increase the understanding of the factors facilitating and hindering implementation of WGS-based diagnostics within health systems. * A cost effectiveness analysis study which will measure the cost effectiveness of newly implemented laboratory methods.

Field and genomic epidemiology data from this project will inform future work on the design of community-level TB elimination strategies in collaboration with Madagascar National TB program

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fokontany Vohibato

Vohibato, Madagascar

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects suspected TB
  • subject living in the study area

Exclusion criteria

  • unable to take a sputum sample

Treatment and study plan

Whole Genome Sequencing testing

Other

Whole Genome Sequencing testing, community-based contact tracing

Primary outcomes

  1. the total number of TB cases detected / 100 000 inhabitants

    Time frame: an average of 1 year

    total number of TB cases detected / 100,000 inhabitants / year in each group during the first year of the intervention.

Sponsors and collaborators

Lead sponsor

Institut Pasteur de Madagascar

Other

Collaborators

  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal
  • The National Tuberculosis Program, Madagascar

Registry information

Official study title

Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar - a Cluster Randomized Controlled Trial to Evaluate Different Community-wide Intervention Strategies.

Acronym: TB_WGS_cRCT

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Jun 6, 2022
Registry last updated
Oct 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.